Stebbins CC - Search Results

1

Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158).

Long EO, Barber DF, Burshtyn DN, Faure M, Peterson M, Rajagopalan S, Renard V, Sandusky M, Stebbins CC, Wagtmann N, Watzl C. Long EO, et al. Among authors: stebbins cc. Immunol Rev. 2001 Jun;181:223-33. doi: 10.1034/j.1600-065x.2001.1810119.x. Immunol Rev. 2001. PMID: 11513144 Review.

2

Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity.

Stebbins CC, Watzl C, Billadeau DD, Leibson PJ, Burshtyn DN, Long EO. Stebbins CC, et al. Mol Cell Biol. 2003 Sep;23(17):6291-9. doi: 10.1128/MCB.23.17.6291-6299.2003. Mol Cell Biol. 2003. PMID: 12917349 Free PMC article.

3

Adhesion to target cells is disrupted by the killer cell inhibitory receptor.

Burshtyn DN, Shin J, Stebbins C, Long EO. Burshtyn DN, et al. Curr Biol. 2000 Jun 29;10(13):777-80. doi: 10.1016/s0960-9822(00)00568-6. Curr Biol. 2000. PMID: 10898979 Free article.

4

Natural killer cells and mast cells from gp49B null mutant mice are functional.

Rojo S, Stebbins CC, Peterson ME, Dombrowicz D, Wagtmann N, Long EO. Rojo S, et al. Among authors: stebbins cc. Mol Cell Biol. 2000 Oct;20(19):7178-82. doi: 10.1128/MCB.20.19.7178-7182.2000. Mol Cell Biol. 2000. PMID: 10982834 Free PMC article.

5

NK cell inhibitory receptors prevent tyrosine phosphorylation of the activation receptor 2B4 (CD244).

Watzl C, Stebbins CC, Long EO. Watzl C, et al. Among authors: stebbins cc. J Immunol. 2000 Oct 1;165(7):3545-8. doi: 10.4049/jimmunol.165.7.3545. J Immunol. 2000. PMID: 11034353

6

Essential role of LAT in T cell development.

Zhang W, Sommers CL, Burshtyn DN, Stebbins CC, DeJarnette JB, Trible RP, Grinberg A, Tsay HC, Jacobs HM, Kessler CM, Long EO, Love PE, Samelson LE. Zhang W, et al. Among authors: stebbins cc. Immunity. 1999 Mar;10(3):323-32. doi: 10.1016/s1074-7613(00)80032-1. Immunity. 1999. PMID: 10204488 Free article.

7

Inhibitory receptor gp49B regulates eosinophil infiltration during allergic inflammation.

Norris HH, Peterson ME, Stebbins CC, McConchie BW, Bundoc VG, Trivedi S, Hodges MG, Anthony RM, Urban JF Jr, Long EO, Keane-Myers AM. Norris HH, et al. Among authors: stebbins cc. J Leukoc Biol. 2007 Dec;82(6):1531-41. doi: 10.1189/jlb.1106667. Epub 2007 Aug 30. J Leukoc Biol. 2007. PMID: 17761953

8

DM-mediated release of a naturally occurring invariant chain degradation intermediate from MHC class II molecules.

Stebbins CC, Peterson ME, Suh WM, Sant AJ. Stebbins CC, et al. J Immunol. 1996 Dec 1;157(11):4892-8. J Immunol. 1996. PMID: 8943393

9

Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules.

Katz JF, Stebbins C, Appella E, Sant AJ. Katz JF, et al. J Exp Med. 1996 Nov 1;184(5):1747-53. doi: 10.1084/jem.184.5.1747. J Exp Med. 1996. PMID: 8920863 Free PMC article.

10

Ig alpha and Ig beta are required for efficient trafficking to late endosomes and to enhance antigen presentation.

Siemasko K, Eisfelder BJ, Stebbins C, Kabak S, Sant AJ, Song W, Clark MR. Siemasko K, et al. J Immunol. 1999 Jun 1;162(11):6518-25. J Immunol. 1999. PMID: 10352267

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page